CBIH — Cannabis Bioscience International Holdings, Inc.
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1411057 ·
Last close
$0.00
Market Cap
$3.49M
52W High
$0.00
52W Low
$0.00
ADV30
14,279,294
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Feb 2026 | 11,205 | 8,160 | -93,259 | -103,933 | 1,544 | 90 | 1,468,674 |
| Nov 2025 | 53,266 | 42,766 | -95,877 | -116,966 | 22,131 | 132 | 1,385,326 |
| May 2025 | 34,956 | 30,411 | -122,990 | -211,744 | 31,880 | 12,952 | 1,195,463 |
| Feb 2025 | 14,931 | -4,465 | -129,234 | -181,243 | 14,886 | 548 | 1,240,474 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-194,468
Investing CF
—
Financing CF
$234,189
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,186,448
Inventory
—
Receivables
$1,266
ST Investments
—
EBIT TTM
$-411,936
Pretax Income TTM
$-614,088
Interest Exp TTM
$202,152
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$123,627
EBITDA
—
Free Cash Flow
$-162,271
Enterprise Value
$4,709,042
Total Cash
$90
Total Debt
$1,221,107
Shares Out
11,626,749,347
Trailing EPS
$0.00
Book Value
$0.00
ROE
—
ROA
-3034.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| May 2025 | 303,022 | -421,365 | -548,820 | 31,880 | 1,195,463 | — | -329,627 |
| May 2024 | 248,841 | -486,140 | -651,345 | 57,162 | 1,136,175 | — | -479,382 |
| May 2023 | 316,825 | -983,371 | -1,032,579 | 43,382 | 635,047 | — | -898,367 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISPC | iSpecimen Inc. | $4.86M | $3.38 | — |
| BUDZ | WEED, INC. | $5.04M | $0.03 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.24M | $1.77 | — |
| VRAX | Virax Biolabs Group Ltd | $1.69M | $0.23 | — |
| BIAF | bioAffinity Technologies, Inc. | $7.48M | $1.65 | — |
News headlines (Yahoo Finance, 1h cache)
CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio
2026-01-21 12:00 · Yahoo
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
2026-01-12 12:00 · Yahoo
CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition
2026-01-05 12:00 · Yahoo
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
2025-12-29 12:00 · Yahoo
CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities
2025-12-22 12:00 · Yahoo
CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline
2025-12-15 12:00 · Yahoo
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
2025-10-13 11:00 · Yahoo
Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
2025-10-06 11:00 · Yahoo
CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center
2025-09-29 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.